Table 1 Sequencing results of serially diluted DNA isolated from two adenocarcinoma cell lines (HT-29 y Caco-2) with known variants in BRAF and MC1R genes.

From: Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

HT-29 in Caco-2 (variant frequency)

BRAF gene, p.V600E (heterozygous)

MC1R gene, p.R160W (heterozygous)

Allele frequency (%)

Coverage (x)

Allele frequency (%)

Coverage (x)

Exp 1

Exp 2

Exp 1

Exp 2

Exp 1

Exp 2

Exp 1

Exp 2

Undiluted (50%)

57.12

52.85

2027

2182

61.42

64.48

1894

2329

1:1 (25%)

26.22

25.69

4366

5780

32.66

32.93

2103

2708

1:3 (12.5%)

13.13

12.85

5620

3507

14.84

15.53

2182

2524

1:24 (2%)

1.82

1.75

3720

3523

1.95

1.21

1894

1981

1:49 (1%)

1.12

0.68

4266

3927

0.80

0.87

2967

2631

1:99 (0.5%)

0.65

0.64

3977

3430

0.57

0.34

2624

1458

1:999 (0.05%)

0.04

0.10

4993

2945

0.03

0.19

3065

3138

  1. Exp: Experiment.